Categories Earnings, LATEST, Other Industries
Earnings: Yeti Q2 profit rises on 12% sales growth; lifts FY19 guidance
YETI Holdings Inc. (NYSE: YETI), a leading manufacturer of coolers, reported stronger than expected earnings for the second quarter of 2019, helped by a 12% increase in revenues. The company also revised up its full-year 2019 guidance.
Net sales rose 12% year-over-year to $231.7 million and came in above the estimates. Sales of the direct-to-consumer channel increased 43%, while wholesale channel sales remained broadly unchanged at $149.2 million. There was a 16% growth in drinkware sales, aided by the introduction of new colorways, sizes, and accessories.
The company reported adjusted earnings of $0.33 per share for the three-month period, up from $0.28 per share in the second quarter of 2018. The bottom line exceeded the forecast. Reported profit was $22.2 million or $0.26 per share, compared to $18.8 million or $0.23 per share last year.
“YETI delivered strong second quarter results, highlighted by our DTC business and demonstrating the brand’s growing reach and relevance during the important gift giving period for moms, dads, and grads,” said CEO Matt Reintjes.
Net sales are currently expected to increase between 13.5% and 14% year-over-year in fiscal 2019, with growth across both channels and led by the DTC channel. The guidance represents an upgrade from the 11.5-13% growth estimated earlier.
The forecast for operating income, as a percentage of sales, is between 13.9% and 14.1%, reflecting margin expansion of 80 to 100 basis points. The guidance for earnings share has been revised up to the range of $0.88 to $0.90, representing a 27-31% annual growth.
Adjusted earnings per share are now expected to be between $1.07 and $1.09, up 18-21% from last year. The earlier forecast was $1.02-$1.06 per share. The company is looking for capital expenditures in the range of $35 million to $40 million. Debt repayments are estimated to be about $80 million.
The value of Yeti’s shares more than doubled since the beginning of the year. The stock closed the last trading session lower.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on